Elicio raises $30M to target cancer vaccines to the lymph nodes
By Mary Romeo, Staff Writer | Mar 27, 2019 | 11:28 PM GMT
Elicio launched Wednesday with $30 million in funding and an immunotherapy strategy aimed at getting cancer vaccines into the lymph nodes, a location that orchestrates immune responses but has been hard to target directly.
Read the full 354 word article
User Sign In
This article may not be distributed to non-subscribers
PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD